Tumor Therapeutic Agent

Patent No. EP3338779 (titled "Tumor Therapeutic Agent") was filed by Eisai R&D Management on Aug 18, 2016. The application was issued on Jun 30, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STADA ARZNEIMITTELMar 29, 2022HAMM & WITTKOPP

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3338779

EISAI R&D MANAGEMENT
Application Number
EP16837150A
Filing Date
Aug 18, 2016
Status
Revoked
Aug 30, 2025
Publication Date
Jun 30, 2021